报价延迟最少15分钟:2026/03/10 07:26 EDT
盘前时段
|
||||
|
44.68 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
44.35
|
|
|
| 价值评估 |
|
盈利(现时/预测)
3.19/4.32
|
|
企业价值
123.31B
|
| 资产负债 |
|
每股账面净值
34.38
|
| 现金流量 |
|
现金流量率
0.11
|
| 损益表 |
|
收益
46.72B
|
|
每股收益
20.03
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China. |
